15. Dezember 2016 | Konsumräume
A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San Francisco, California, USA
A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San Francisco, California, USA
Amos Irwin, , Ehsan Jozaghi, Ricky N. Bluthenthal, Alex H. Kral
Journal of Drug Issues
First published date: December-13-2016
10.1177/002204…